{"id":"https://openalex.org/W3135873052","doi":"https://doi.org/10.1080/00498254.2021.1890275","title":"Pharmacokinetics and metabolism of brexpiprazole, a novel serotonin-dopamine activity modulator and its main metabolite in rat, monkey and human","display_name":"Pharmacokinetics and metabolism of brexpiprazole, a novel serotonin-dopamine activity modulator and its main metabolite in rat, monkey and human","publication_year":2021,"publication_date":"2021-03-09","ids":{"openalex":"https://openalex.org/W3135873052","doi":"https://doi.org/10.1080/00498254.2021.1890275","mag":"3135873052","pmid":"https://pubmed.ncbi.nlm.nih.gov/33685346"},"language":"en","primary_location":{"id":"doi:10.1080/00498254.2021.1890275","doi":"https://doi.org/10.1080/00498254.2021.1890275","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00498254.2021.1890275","pdf_url":null,"source":{"id":"https://openalex.org/S48760969","display_name":"Xenobiotica","issn_l":"0049-8254","issn":["0049-8254","1366-5928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/dataset/Pharmacokinetics_and_metabolism_of_brexpiprazole_a_novel_serotonin-dopamine_activity_modulator_and_its_main_metabolite_in_rat_monkey_and_human/14184813","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103958512","display_name":"Hiroyuki Sasabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hiroyuki Sasabe","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110161080","display_name":"Toshihisa Koga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshihisa Koga","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Masayuki Furukawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masayuki Furukawa","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111164659","display_name":"Masayuki Matsunaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masayuki Matsunaga","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041613271","display_name":"Yosuke Kaneko","orcid":"https://orcid.org/0009-0000-5980-5741","observed_orcids":["https://orcid.org/0009-0000-5980-5741","https://orcid.org/0009-0005-8355-3931"]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yosuke Kaneko","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Noriyuki Koyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriyuki Koyama","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111798419","display_name":"Yukihiro Hirao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yukihiro Hirao","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hitomi Akazawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitomi Akazawa","raw_affiliation_strings":["Department of CNS research, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of CNS research, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084115623","display_name":"Mitsuhiko Kawabata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110656","display_name":"Shin Nippon Biomedical Laboratories (Japan)","ror":"https://ror.org/01sqm5e44","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210110656"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuhiko Kawabata","raw_affiliation_strings":["Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories, Ltd, Kainan, Wakayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics and Bioanalysis Center, Shin Nippon Biomedical Laboratories, Ltd, Kainan, Wakayama, Japan","institution_ids":["https://openalex.org/I4210110656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082138706","display_name":"Eiji Kashiyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Eiji Kashiyama","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010148036","display_name":"Kenji Takeuchi","orcid":"https://orcid.org/0000-0001-8769-8955","observed_orcids":["https://orcid.org/0000-0001-8769-8955","https://orcid.org/0000-0002-6180-7663"]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Takeuchi","raw_affiliation_strings":["Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd, Kawauchi-cho, Tokushima, Japan","institution_ids":["https://openalex.org/I114030911"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5103958512"],"corresponding_institution_ids":["https://openalex.org/I114030911"],"apc_list":null,"apc_paid":null,"fwci":1.9183,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.83525156,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"51","issue":"5","first_page":"590","last_page":"604"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brexpiprazole","display_name":"brexpiprazole","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9789999723434448},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.9660000205039978},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.9160000085830688},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":1.0},{"id":"https://openalex.org/keywords/species-differences","display_name":"species differences","score":0.382999986410141},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.5820000171661377},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.8510000109672546},{"id":"https://openalex.org/keywords/d2-receptor-affinity","display_name":"D2 receptor affinity","score":0.6980000138282776},{"id":"https://openalex.org/keywords/brain-distribution","display_name":"brain distribution","score":0.3269999921321869},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8381789922714233},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7564756870269775},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.7023745775222778},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5865505933761597},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.5417665839195251},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5038899779319763},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.477398544549942},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.4608568251132965},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.4500954747200012},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.4170614182949066},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3218865990638733},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2941397428512573},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25151485204696655},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.24308034777641296},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000882","descriptor_name":"Haplorhini","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/00498254.2021.1890275","doi":"https://doi.org/10.1080/00498254.2021.1890275","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00498254.2021.1890275","pdf_url":null,"source":{"id":"https://openalex.org/S48760969","display_name":"Xenobiotica","issn_l":"0049-8254","issn":["0049-8254","1366-5928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica","raw_type":"journal-article"},{"id":"pmid:33685346","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33685346","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica; the fate of foreign compounds in biological systems","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/14184813","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Pharmacokinetics_and_metabolism_of_brexpiprazole_a_novel_serotonin-dopamine_activity_modulator_and_its_main_metabolite_in_rat_monkey_and_human/14184813","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.14184813.v1","doi":"https://doi.org/10.6084/m9.figshare.14184813.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.14184813.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/14184813","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Pharmacokinetics_and_metabolism_of_brexpiprazole_a_novel_serotonin-dopamine_activity_modulator_and_its_main_metabolite_in_rat_monkey_and_human/14184813","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W2034629571","https://openalex.org/W2074631079","https://openalex.org/W2120893202","https://openalex.org/W2151839057","https://openalex.org/W2154299176","https://openalex.org/W2155268095","https://openalex.org/W2304131176","https://openalex.org/W2317377499","https://openalex.org/W2513889801","https://openalex.org/W2740384019","https://openalex.org/W2804126510","https://openalex.org/W2924105976","https://openalex.org/W3134712545","https://openalex.org/W4250218096"],"related_works":["https://openalex.org/W3134712545","https://openalex.org/W2924105976","https://openalex.org/W2151839057","https://openalex.org/W4407390908","https://openalex.org/W7157299353","https://openalex.org/W2340305300","https://openalex.org/W3184469587","https://openalex.org/W4396745638","https://openalex.org/W2115217780","https://openalex.org/W2339379954"],"abstract_inverted_index":{"The":[0,75],"pharmacokinetics":[1],"of":[2,16,79,132,141],"brexpiprazole":[3,17,80,161,169],"were":[4,41,65,125,154],"investigated":[5],"in":[6,8,11,18,49,55,70,85,109,113,128,156,165],"the":[7,50,56,93,114,118,129,157,166],"vitro":[9],"and":[10,20,24,31,36,52,63,67,72,87,111,123,143,181,190],"vivo.The":[12],"total":[13],"body":[14,61],"clearance":[15],"rat":[19,51,71],"monkey":[21],"was":[22,34,81,95,107,137],"2.32":[23],"0.326":[25],"L/h/kg,":[26],"respectively,":[27],"after":[28],"intravenous":[29],"administration,":[30],"oral":[32],"availability":[33],"13.6%":[35],"31.0%,":[37],"respectively.":[38,74],"Dose-dependent":[39],"exposures":[40],"observed":[42],"at":[43],"dose":[44],"ranges":[45],"between":[46],"1\u201330":[47],"mg/kg":[48,54],"0.1\u20133":[53],"monkey.Brexpiprazole":[57],"distributed":[58],"widely":[59],"to":[60,188],"tissues,":[62],"Vd,z":[64],"2.81":[66],"1.82":[68],"L/kg":[69],"monkey,":[73],"serum":[76],"protein":[77],"binding":[78],"99%":[82],"or":[83],"more":[84],"animals":[86,110],"human.":[88],"Uniform":[89],"distribution":[90],"character":[91],"among":[92],"species":[94,184],"suggested":[96],"by":[97],"a":[98,171],"traditional":[99],"animal":[100],"scale-up":[101],"method.A":[102],"common":[103],"main":[104],"metabolite,":[105],"DM-3411":[106,133,145],"found":[108],"humans":[112],"metabolic":[115,177],"reactions":[116],"with":[117,149,175,186],"liver":[119],"S9":[120],"fraction.":[121],"CYP3A4":[122],"CYP2D6":[124],"predominantly":[126],"involved":[127,164],"metabolism.The":[130],"affinity":[131,150],"for":[134],"D2":[135],"receptors":[136],"lower":[138],"than":[139,152],"that":[140,160],"brexpiprazole,":[142],"neither":[144],"nor":[146],"any":[147],"metabolites":[148],"other":[151],"M3":[153],"detected":[155],"brain,":[158],"demonstrating":[159],"is":[162],"only":[163],"pharmacological":[167],"effects.Overall,":[168],"has":[170],"simple":[172],"pharmacokinetic":[173],"profile":[174],"good":[176],"stability,":[178],"linear":[179],"kinetics,":[180],"no":[182],"remarkable":[183],"differences":[185],"regard":[187],"metabolism":[189],"tissue":[191],"distribution.":[192]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-03-15T00:00:00"}